Starlight Therapy in Palliative Care
Starlight Therapy as a Non-Pharmacological Nursing Intervention in Palliative Care
1 other identifier
observational
100
1 country
1
Brief Summary
Starlight Therapy™ has been shown to help alleviate end-of-life symptoms in Palliative Care patients and reduce the need for PRN or "as needed" medications. This study will investigate the efficacy of this intervention on the symptom of anxiety using a mixed-method analysis. The primary investigator hypothesizes that any anti-anxiolytic effects could be caused by the Intrinsically Photosensitive Retinal Ganglion Cell neural pathway to the amygdala.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2018
CompletedFirst Posted
Study publicly available on registry
October 23, 2018
CompletedStudy Start
First participant enrolled
December 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2027
Study Completion
Last participant's last visit for all outcomes
November 30, 2027
August 23, 2024
February 1, 2024
12 months
October 18, 2018
August 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Using Starlight Therapy to measure Change in Unpleasant Symptoms in Palliative Care Patients as measured using the ESAS (Edmonton Symptom Assessment System) Scale. On a scale of 0-10, with 0 = no symptom and 10= symptom is worst outcome possible.
Edmonton Assessment scale questionnaire will be completed before Starlight Therapy and after 2 hours.
2 hours of Starlight Therapy
Study Arms (1)
Palliative Care Patients
Palliative care Patients meeting criteria will receive Starlight Therapy
Interventions
Starlight Projector will be placed in patients' rooms and project starlight on the ceilings and walls in an effort to reduce unpleasant symptoms
Eligibility Criteria
Patients in an inpatient palliative care Setting who meet the specified criteria for inclusion in the study
You may qualify if:
- \. ESAS indicates at least one of the following symptoms:
- Insomnia
- Anxiety
- Restlessness
- Dyspnea
- Pain
You may not qualify if:
- Clinical Diagnosis of blindness
- ESAS does not include any of the flowing symptoms:
- Insomnia
- Anxiety
- Restlessness
- Dyspnea
- Pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Victoria General Hospital
Halifax, Nova Scotia, Canada
Related Publications (1)
Evaluation of a Low-Light Intervention-Starlight Therapy-for Agitation, Anxiety, Restlessness, Sleep Disturbances, Dyspnea, and Pain at End of Life. (2017). Journal of Hospice & Palliative Nursing, 19(3), 221-222. doi:10.1097/njh.0000000000000343
BACKGROUND
Related Links
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2018
First Posted
October 23, 2018
Study Start (Estimated)
December 15, 2026
Primary Completion (Estimated)
November 30, 2027
Study Completion (Estimated)
November 30, 2027
Last Updated
August 23, 2024
Record last verified: 2024-02